# Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy

Source: https://onco.cc/trials/nct03977194/  
OnCo record `nct03977194` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of carboplatin, paclitaxel / nab-paclitaxel and atezolizumab in lung cancer, run by Intergroupe Francophone de Cancerologie Thoracique, active but no longer recruiting.

## Summary

Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy is a phase 3, randomised interventional study registered as NCT03977194 by Intergroupe Francophone de Cancerologie Thoracique, with a registry enrolment figure of 510 participants, started 2019-07-23 and due to reach its primary completion in 2024-08-31. Interventions recorded: Carboplatin; Paclitaxel; Atezolizumab. Conditions listed: Non Small Cell Lung Cancer Metastatic. Primary outcome: Overall Survival. Lung eligibility wording from the registry: "Histologically confirmed NSCLC". Sites: France. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-25
- Also known as: ELDERLY
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT03977194
- Phase: 3
- Setting: Phase III Randomized Trial of Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Monthly Carboplatin With Weekly Paclitaxel Chemotherapy
- Sponsor: Intergroupe Francophone de Cancerologie Thoracique
- Enrolled: 510

## Sources

- ClinicalTrials.gov NCT03977194: https://clinicaltrials.gov/study/NCT03977194

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Atezolizumab](https://onco.cc/drugs/atezolizumab/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct03977194.json